Navigation Links
Mesa Labs Announces the Appointment of New CEO

LAKEWOOD, Colo., March 10 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: MLAB), a supplier of instruments and consumables for healthcare and manufacturing quality control applications, today announced the appointment of Dr. John J. Sullivan to the position of Chief Executive Officer (CEO), replacing Luke R. Schmieder, who has been the CEO since founding the company in 1982. Mr. Schmieder is retiring from Mesa and resigning his positions of CEO and Treasurer, but will retain his position as Chairman of the Board of Directors. In addition to assuming the new CEO position, Dr. Sullivan will retain his position as President and will be named to the Board of Directors.

"The Board is delighted that John has agreed to assume the position of CEO and we welcome him to the Board of Directors," said Luke R. Schmieder, Chairman of Mesa Laboratories Inc. "John has done an excellent job since joining Mesa in focusing our strategies on growth. During his tenure with Mesa, we have strengthened our distribution channels, introduced several new products, and completed the acquisition of Raven Laboratories. Our revenue and net income have doubled over this period of time. The Board of Directors and I will work with John in guiding the Company's growth strategies in the years ahead. We feel certain that John looks forward to continuing our efforts to grow the Company and shareholder value as we have in the past."

Dr. Sullivan has been with Mesa since 2004 when he joined the company as Vice President of Sales and Marketing. He was named to the position of President and Chief Operating Officer in 2006 and has been responsible for day-to-day operations of the company since that time. Prior to joining Mesa, Dr. Sullivan was with Varian, Inc., a major analytical instrument manufacturer, for 16 years where he held various positions in Research and Development, Sales and Marketing Management and in Business Development. Prior to Varian, Dr. Sullivan was with the U.S. Food and Drug Administration's Seattle District Laboratory for 5 years where he held the position of Senior Research Scientist. Dr. Sullivan holds a Bachelor of Science degree in Biology from Western Washington University and a Ph.D. degree in Food Science from the University of Washington.

"I would like to thank the Board for their vote of confidence," said Dr. Sullivan. "In my new role at Mesa, I look forward to working with the Board, our management team, and all of Mesa's employees to further the company's goals. I think I speak for everyone in the Mesa organization and our shareholders in expressing a note of gratitude to Luke. His management of Mesa during the past 27 years has created a highly profitable, growing company that holds strong positions in its key markets. I plan to manage the company based on the same principles Luke established, high ethical standards and always putting the shareholder's interests first. Moving forward, our focus is on profitable growth, continued improvement in our distribution channels, increased flow of new products to the marketplace, and new strategic acquisitions. We have a skilled team, strong foundation and excellent prospects in the years ahead. I look forward to many years of building a larger, stronger, more profitable Mesa Labs."

Mesa Laboratories, Inc. develops, manufactures and markets electronic instruments and disposables for industrial, pharmaceutical and medical applications.

This news release contains forward-looking statements which involve risks and uncertainties. The Company's actual results could differ materially from those in any such forward-looking statements. Additional information concerning important factors that could cause results to differ materially from those in any such forward-looking statement is contained in the Company's Annual Report on Form-10K for the year ended March 31, 2008 as filed with the Securities and Exchange Commission, and from time to time in the Company's other reports on file with the Commission.

SOURCE Mesa Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
(Date:11/30/2015)... ... December 01, 2015 , ... ... Colon as a 2015-2016 inductee into its VIP Woman of the Year ... is the nation’s leading networking organization exclusively for professional women, boasting 850,000 members ...
(Date:11/30/2015)... ... December 01, 2015 , ... The National ... 2015-2016 inductee into its VIP Woman of the Year Circle. She is recognized ... networking organization exclusively for professional women, boasting 850,000 members and over 200 operating ...
(Date:11/30/2015)... ... December 01, 2015 , ... Live Very Well is ... insurance plans on . The multi-carrier insurance exchange platform offers individual ... allowing consumers to compare, quote and match plans to meet their needs. ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... Until now, ... criteria set forth in the MOMS (Management of Myelomeningocele Study) trial. One of these ... Control and Prevention), a BMI of 18.5 to 24.9 is considered normal, 25 - ...
(Date:11/30/2015)... ... 2015 , ... Stress, anxiety, illness, infection or even a need for eyeglasses ... Heather Spader, MD, a new pediatric neurosurgeon at Joe DiMaggio Children’s Hospital in Hollywood, ... tumors. , “Bad headaches that don’t go away, that don’t have any ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015   Royal Philips ... ScanWise Implant, the industry,s first MRI guided user interface ... scanning of patients with MR Conditional implants, such as ... the 2015 Radiological Society of North America Annual ... exams and supports diagnostic confidence of this growing patient ...
(Date:11/30/2015)... Nov. 30, 2015 Baxalta Incorporated ... leader dedicated to delivering transformative therapies to ... conditions, today announced the launch and first ... an extended circulating half-life recombinant factor VIII ... full-length ADVATE [Antihemophilic Factor (Recombinant)]. The treatment ...
(Date:11/30/2015)... PUNE, India , November 30, 2015 ... new market research report "Dental Lasers Market by Product (Soft ... Treatment, Periodontitis), End User (Hospitals, Clinics), and Geography - Global ... USD 224.7 Million by 2020, at a CAGR of 5.2% ... , Browse 140 market data Tables and 62 Figures spread ...
Breaking Medicine Technology: